Vanda Pharmaceuticals
VNDA
#8548
Rank
A$0.39 B
Marketcap
A$6.54
Share price
0.88%
Change (1 day)
-22.31%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2026 (TTM): -A$0.28 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are A$0.21 Billion. In 2025 the company made an earning of -A$0.22 Billion a decrease over its 2024 earnings that were of -A$58.19 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.28 Billion25.94%
2025 -A$0.22 Billion271.79%
2024 -A$58.19 Million191.43%
2023 -A$19.97 Million-320.45%
2022 A$9.05 M-84.99%
2021 A$60.34 M54.8%
2020 A$38.98 M19.42%
2019 A$32.64 M4.93%
2018 A$31.1 M-228.6%
2017 -A$24.19 Million-8.98%
2016 -A$26.58 Million-53.79%
2015 -A$57.51 Million-30.18%
2014 -A$82.37 Million173.08%
2013 -A$30.17 Million-25.33%
2012 -A$40.4 Million163.61%
2011 -A$15.33 Million-221.15%
2010 A$12.64 M-124.53%
2009 -A$51.57 Million-29.44%
2008 -A$73.08 Million-36.2%
2007 -A$0.12 Billion21.81%
2006 -A$94.04 Million170.55%
2005 -A$34.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.50 B-14,215.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.21 B-8,459.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$9.88 B-3,820.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$48.07 B-18,194.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$11.00 B-4,241.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$17.04 B-6,514.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-A$4.02 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA